Clinical Management of Shock - The Science and Art of Physiological Restoration 2020
DOI: 10.5772/intechopen.82156
|View full text |Cite
|
Sign up to set email alerts
|

New Biomarkers of Sepsis with Clinical Relevance

Abstract: A 2016 task force convened by multiple societies proposed a new definition of sepsis, termed Sepsis 3. The new clinical diagnosis of sepsis is based on variation points in the Sequential (Sepsis-related)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 74 publications
0
2
0
Order By: Relevance
“…Besides symptoms and signs for the early diagnosis of sepsis, available biomarkers are important for the following treatment of sepsis. Some biological markers have been established such as lactate, C-reactive protein (CRP), procalcitonin (PCT), B-type natriuretic peptide (BNP), and soluble RAGE (sRAGE) in sepsis, while lack of sensitivity and specificity limit their clinical application ( Oberhoffer et al, 1999 ; Phua et al, 2008 ; Hamasaki et al, 2014 ; Débora Maria da Gomes Cunha and Yoshio Hamasaki, 2019 ). It is of prime importance to identify more effective technologies and specific biomarkers for sepsis.…”
Section: Introductionmentioning
confidence: 99%
“…Besides symptoms and signs for the early diagnosis of sepsis, available biomarkers are important for the following treatment of sepsis. Some biological markers have been established such as lactate, C-reactive protein (CRP), procalcitonin (PCT), B-type natriuretic peptide (BNP), and soluble RAGE (sRAGE) in sepsis, while lack of sensitivity and specificity limit their clinical application ( Oberhoffer et al, 1999 ; Phua et al, 2008 ; Hamasaki et al, 2014 ; Débora Maria da Gomes Cunha and Yoshio Hamasaki, 2019 ). It is of prime importance to identify more effective technologies and specific biomarkers for sepsis.…”
Section: Introductionmentioning
confidence: 99%
“…Early diagnosis in order to early intervention before organ dysfunction is critical to improving survival rate of sepsis ( 4 ). Due to their poor sensitivity and specificity in assessing the substantial disease heterogeneity, the existing biological markers cannot be used for sepsis prognosis prediction ( 5 8 ). Therefore, further studies are required to investigate the pathogenesis of sepsis and identify more sensitive and specific therapeutic targets.…”
Section: Introductionmentioning
confidence: 99%